Navigation Links
Watson Acquires Uteron Pharma SA
Date:1/23/2013

PARSIPPANY, N.J., Jan. 23, 2013 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that it has completed the acquisition of Belgium-based Uteron Pharma SA for $150 million in cash up front, and up to $155 million in potential future milestone payments.  The acquisition of Uteron expands Watson's Global Brands pipeline of Women's Health products including two potential near term global commercial opportunities in contraception and infertility, and one novel oral contraceptive, projected to launch globally in 2018.  Several additional products in earlier stages of development are also included in the acquisition.  The Company said the transaction is expected to be minimally dilutive to non-GAAP earnings in 2013 and 2014, and accretive in 2015.

"This is a strategic acquisition of a solid pipeline, sound development expertise, and sufficient manufacturing capacity to generate value for shareholders within the next two years, and provide the potential of multiple global product introductions through the latter half of the decade," said Fred Wilkinson , President of Watson Global Brands and Biosimilars.  "We have structured the financials of the acquisition to reflect the immediate value of the late stage pipeline, with approximately $45 million in near-term milestones and appropriately balancing the development risks and investments required to commercialize these assets, when compared to the longer-term opportunities. 

"The acquisition capitalizes on the growing potential of the expanded global commercial footprint for our Women's Health Brand franchise following the Actavis acquisition.  As a result of the Uteron acquisition, Watson welcomes the opportunity to access resources within the Walloon Region of Belgium'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Watson to Present at the 2012 Piper Jaffray Health Care Conference
2. Watson to Present at the 2012 Annual Credit Suisse Healthcare Conference
3. Watson Third Quarter 2012 Non-GAAP Diluted EPS Increases 24% to $1.35; Net Revenue Increases 19% to $1.29 Billion
4. Watson Announces Global Generics Management Team
5. Watson Announces New Name -- Actavis -- for Global Operations
6. Cleveland Clinic and IBM Work to Advance Watsons Use in the Medical Training Field
7. Watson Announces Sale of Rugby OTC Product Trademark and Assets to Major Pharmaceuticals, a division of The Harvard Drug Group, LLC
8. Watson to Present at the 2012 Bank of America Merrill Lynch Global Healthcare Conference
9. Watson to Present at the Morgan Stanley 2012 Global Healthcare Conference
10. Watson Applauds GPhA Study Demonstrating $1 Trillion in Prescription Drug Savings from Generic Medicines
11. Watson and Actavis Receive FTC Second Request
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Ala. , June 19, 2013 DST ... solutions and services to health plans, integrated delivery systems, ... its Medical Drug Management Service (MDMS) has ... clinically edit and automate the pricing of medical prescription ... gain efficiencies by automating their medical drug claims processes. ...
(Date:6/19/2013)... N.J. , June 19, 2013 /PRNewswire-iReach/ ... Pharma, a new specialty pharmaceutical company dedicated ... of innovative injectable and sustained release drug ... unmet medical needs, today announced the acquisition ... Linker Technology®) platform and associated product pipeline. ...
(Date:6/19/2013)... Pharma IQ is pleased to announce ... of the results from an industry survey conducted earlier this ... that CROs would be an area of active investment in ... 6 or more clinical trials in the BRIC region. The ... USA Summit explores the latest trends, challenges ...
Breaking Medicine Technology:Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 2Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 3Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 3Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 4Pharma IQ Presents the Latest Trends in Clinical Trial Supply 2
... ... ... ... ...
... ... ... ... ...
Cached Medicine Technology:Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 2Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 3Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 4Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 5Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 6Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 7Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 8Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 9Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 10Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 11Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 12Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 13Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 14Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 15Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 16Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 17Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 18Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 19Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 20Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 2Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 3Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 4Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 5Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 6Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 7Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 8
(Date:6/19/2013)... Triangle Park, NC (PRWEB) June 19, 2013 ... Entegrion , Inc., announced organizational changes to advance ... John B. Mowell said, “To support the advanced ... Directors has made changes to the Company’s management ... , The Company announced that Michael ...
(Date:6/19/2013)... 2013 PREFERRED Therapy Providers, Inc. (PREFERRED) ... to offer a new Medicare Advantage Plan for ... Yavapai and Mohave, Arizona counties. The agreement takes effect ... January 1, 2013 and Maricopa and Pima counties will ... the parent company of WellCare of Arizona has Medicare ...
(Date:6/19/2013)... 2013 Alternatives, a revolutionary new treatment ... quit using drugs while allowing them to continue drinking ... of Alternatives, believe that abstinence-only approaches force people to ... and that this approach hurts instead of helping. ... United States need treatment for addiction but only 3 ...
(Date:6/19/2013)... 2013 At a Travel Services Member Conference, ... growth that has occurred over the last year since he ... said, "Travel Services has added vendors, lowered prices of travel ... Membership is up, even in the tough economy, and they've ... members." , Having been in the Travel Business and Timeshare ...
(Date:6/19/2013)... In 2011, the value of the ... Generic drugs form the largest sector, accounting for nearly ... industry is a significant contributor to the local economy; ... Approximately 50% of the total domestic chemical industry output ... Galenika and Zdravlje Actavis are key participants in the ...
Breaking Medicine News(10 mins):Health News:Entegrion Announces Organizational Changes to Support Advanced Product Development 2Health News:Entegrion Announces Organizational Changes to Support Advanced Product Development 3Health News:PREFERRED Therapy Providers, Inc. and WellCare of Arizona Finalize Their Agreement to Offer Medicare Advantage Plan to PREFERRED's Arizona Provider Network 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 3Health News:Former Owner Eric Shuman Endorses New Owners and Changes Made in Last Year Since Shuman Sold Travel Services Center at Member Conference 2Health News:Serbian Pharmaceutical Market Scrutinized by CUBE in Topical Report Now Available at MarketPublishers.com 2
... 1, 2010) While health policy researchers commonly suggest ... provided can be attributed to hospital costs or physician ... a specific surgical procedure minimally invasive aneurysm repair ... Researchers at Cedars-Sinai Medical Center in Los Angeles have ...
... ... on simple, healthier cooking while offering time and stress relief at home , ... (PRWEB) April 2, 2010 -- As the ... TV shows and White House campaigns – Dream Dinners , Inc. today announced the ...
... ... ... Tahitian Noni® International (TNI) have revealed that the noni fruit is also ... body to adapt to stress. Noni assists resistance to a broad range of negative physical, ...
... ... the new work selection process that virtually guarantees that people will discover, ... more completely than ever before. These are the jobs that best match ... both employees and owners will be greatly rewarded for the valued results ...
... ... Sale , ... (PRWEB) April 2, 2010 -- New Chapter Press announced that the newly-updated memoir ... today and is now available in book stores and via internet book retailers in North ...
... ... Denial, , ... -- Every year, Sokolove Law hears from thousands of consumers who believe they have been ... a policyholder who has a legitimate claim. In response to this growing “bad faith” ...
Cached Medicine News:Health News:Cedars-Sinai study examines regional use of minimally invasive repair of aneurysms 2Health News:Dream Dinners Launches Nationwide Program to Help Families Eat Healthier 2Health News:Dream Dinners Launches Nationwide Program to Help Families Eat Healthier 3Health News:Adaptogenic Properties of Tahitian Noni Bioactive Beverages Revealed 2Health News:Go to Play Every Day & Call it Work: Finally-The Book to Get the Best Jobs For Everyone 2Health News:Rod Laver Memoir 'The Education Of A Tennis Player' Officially Released By New Chapter Press 2Health News:Rod Laver Memoir 'The Education Of A Tennis Player' Officially Released By New Chapter Press 3Health News:Sokolove Law Helps Thousands of Consumers Fight Unfair Disability Insurance Denial 2Health News:Sokolove Law Helps Thousands of Consumers Fight Unfair Disability Insurance Denial 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: